Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis.

Kodama S, Davis M, Faustman DL.

Cell Mol Life Sci. 2005 Aug;62(16):1850-62. Review.

PMID:
15968469
[PubMed - indexed for MEDLINE]
2.

Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments.

Kollias G, Kontoyiannis D.

Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):315-21. Review.

PMID:
12220546
[PubMed - indexed for MEDLINE]
3.

Role of defective apoptosis in type 1 diabetes and other autoimmune diseases.

Hayashi T, Faustman DL.

Recent Prog Horm Res. 2003;58:131-53. Review.

PMID:
12795417
[PubMed - indexed for MEDLINE]
4.

Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.

Bhattacharyya S, Mandal D, Sen GS, Pal S, Banerjee S, Lahiry L, Finke JH, Tannenbaum CS, Das T, Sa G.

Cancer Res. 2007 Jan 1;67(1):362-70.

PMID:
17210719
[PubMed - indexed for MEDLINE]
Free Article
5.

Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells.

Ortis F, Pirot P, Naamane N, Kreins AY, Rasschaert J, Moore F, Théâtre E, Verhaeghe C, Magnusson NE, Chariot A, Orntoft TF, Eizirik DL.

Diabetologia. 2008 Jul;51(7):1213-25. doi: 10.1007/s00125-008-0999-7. Epub 2008 May 8.

PMID:
18463842
[PubMed - indexed for MEDLINE]
6.

Defective function of the proteasome in autoimmunity: involvement of impaired NF-kappaB activation.

Hayashi T, Faustman D.

Diabetes Technol Ther. 2000 Autumn;2(3):415-28. Review.

PMID:
11467344
[PubMed - indexed for MEDLINE]
7.

Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.

Miyazaki A, Kitaichi N, Ohgami K, Iwata D, Jin XH, Iwabuchi K, Morohashi T, Ohno S, Onoé K.

Graefes Arch Clin Exp Ophthalmol. 2008 May;246(5):747-57. Epub 2007 Dec 18.

PMID:
18087711
[PubMed - indexed for MEDLINE]
9.

Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.

Imre G, Gekeler V, Leja A, Beckers T, Boehm M.

Cancer Res. 2006 May 15;66(10):5409-18.

PMID:
16707469
[PubMed - indexed for MEDLINE]
Free Article
10.

Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.

Tse AK, Wan CK, Shen XL, Yang M, Fong WF.

Biochem Pharmacol. 2005 Nov 15;70(10):1443-57. Epub 2005 Sep 21.

PMID:
16181613
[PubMed - indexed for MEDLINE]
11.

The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.

Lee HJ, Oh YK, Rhee M, Lim JY, Hwang JY, Park YS, Kwon Y, Choi KH, Jo I, Park SI, Gao B, Kim WH.

J Mol Biol. 2007 Jun 15;369(4):967-84. Epub 2007 Apr 1.

PMID:
17475277
[PubMed - indexed for MEDLINE]
12.

Perturbations in nuclear factor-kappaB or c-Jun N-terminal kinase pathways in pancreatic beta cells confer susceptibility to cytokine-induced cell death.

Thomas HE, Angstetra E, Fernandes RV, Mariana L, Irawaty W, Jamieson EL, Dudek NL, Kay TW.

Immunol Cell Biol. 2006 Feb;84(1):20-7. Epub 2005 Nov 7.

PMID:
16277639
[PubMed - indexed for MEDLINE]
13.

Alternate pathways preserve tumor necrosis factor-alpha production after nuclear factor-kappaB inhibition in neonatal cerebral hypoxia-ischemia.

Nijboer CH, Heijnen CJ, Groenendaal F, van Bel F, Kavelaars A.

Stroke. 2009 Oct;40(10):3362-8. doi: 10.1161/STROKEAHA.109.560250. Epub 2009 Jul 23.

PMID:
19628795
[PubMed - indexed for MEDLINE]
Free Article
14.

The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.

Mauro C, Zazzeroni F, Papa S, Bubici C, Franzoso G.

Methods Mol Biol. 2009;512:169-207. doi: 10.1007/978-1-60327-530-9_10.

PMID:
19347278
[PubMed - indexed for MEDLINE]
15.

Genomic expression profiling of TNF-alpha-treated BDC2.5 diabetogenic CD4+ T cells.

Lee LF, Lih CJ, Huang CJ, Cao T, Cohen SN, McDevitt HO.

Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10107-12. doi: 10.1073/pnas.0803336105. Epub 2008 Jul 15.

PMID:
18632574
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Anti-TNF-alpha antibody therapies in autoimmune diseases.

Chatzantoni K, Mouzaki A.

Curr Top Med Chem. 2006;6(16):1707-14. Review.

PMID:
17017952
[PubMed - indexed for MEDLINE]
17.
18.

TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.

Qin Y, Auh S, Blokh L, Long C, Gagnon I, Hamann KJ.

Cell Mol Immunol. 2007 Feb;4(1):43-52.

PMID:
17349210
[PubMed - indexed for MEDLINE]
Free Article
19.

Sulforaphane suppresses TNF-alpha-mediated activation of NF-kappaB and induces apoptosis through activation of reactive oxygen species-dependent caspase-3.

Moon DO, Kim MO, Kang SH, Choi YH, Kim GY.

Cancer Lett. 2009 Feb 8;274(1):132-42. doi: 10.1016/j.canlet.2008.09.013. Epub 2008 Oct 25.

PMID:
18952368
[PubMed - indexed for MEDLINE]
20.

Central role of defective apoptosis in autoimmunity.

Kühtreiber WM, Hayashi T, Dale EA, Faustman DL.

J Mol Endocrinol. 2003 Dec;31(3):373-99. Review.

PMID:
14664701
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk